Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 11Pain 2Depression 2Sleep Disorders, Circadian Rhythm 1Radiodermatitis 1Parasomnias 1Female Breast Cancer 1Breast Cancer - Female 1Anxiety Disorders 1

Interventions

Psychiatric Rehabilitation 13Therapeutics 7Early Intervention, Educational 5Yoga 4Surveys and Questionnaires 4Methods 4Saline Solution 3Mindfulness-Based Cognitive Therapy 3Mindfulness 3Esketamine 3Chemotherapy, Adjuvant 3Transcranial Direct Current Stimulation 2Melatonin 2Gabapentin 2Exercise Therapy 2Exercise 2Educational Status 2Counseling 2Control Groups 2Cognitive Behavioral Therapy 2Acupuncture Therapy 2abacavir 1Water 1Venlafaxine Hydrochloride 1Vegetables 1Typhoid-Paratyphoid Vaccines 1Therapeutic Touch 1Tamoxifen 1Stress Mindset Measure 1Sertraline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Depression × Melatonin × Breast × Clear all
NCT03205033 2017-07-02

Melatonin as a Circadian Clock Regulator, Neuromodulator and Myelo-protector in Adjuvant Breast Cancer Chemotherapy

Hospital de Clinicas de Porto Alegre

Phase 2 Completed
36 enrolled
Breast

Breast Neoplasms, Depression, Pain, Sleep Disorders, Circadian Rhythm

NCT01355523 2014-05-06

MELODY

Herlev Hospital

Phase 2/3 Terminated
54 enrolled 27 charts
Breast

Anxiety Disorders, Breast Neoplasms, Depression, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡